Structure |
Chemical Name |
CAS |
MF |
![6,6'-oxybis(3-formylbenzonitrile)](/) |
6,6'-oxybis(3-formylbenzonitrile) |
|
|
![4-乙基-2,3-二氧代-N-苯基哌嗪-1-甲酰胺](/CAS/20200611/GIF/65322-79-4.gif) |
4-乙基-2,3-二氧代-N-苯基哌嗪-1-甲酰胺 |
65322-79-4 |
C13H15N3O3 |
![Cabozantinib Impurity EXA](/CAS/20210111/GIF/1431468-36-8.gif) |
Cabozantinib Impurity EXA |
1431468-36-8 |
C17H14F2N2O2 |
![Tafluprost Impurity 13](/) |
Tafluprost Impurity 13 |
|
|
![GLICLAZIDE IMPURITY B](/) |
GLICLAZIDE IMPURITY B |
|
|
![ISOPROMETHAZINE HYDROCHLORIDE](/CAS/GIF/5568-90-1.gif) |
ISOPROMETHAZINE HYDROCHLORIDE |
5568-90-1 |
C17H21ClN2S |
![ZOLPIDEM IMPURITY A](/StructureFile/ChemBookStructure22/GIF/CB5588505.gif) |
ZOLPIDEM IMPURITY A |
1346600-85-8 |
C19H21N3O |
![Carbamic acid, N-[(1S,2S,4S)-2-hydroxy-4-[[(2-methylpropoxy)carbonyl]amino]-5-phenyl-1-(phenylmethyl)pentyl]-, 5-thiazolylmethyl ester](/CAS/20200515/GIF/1010809-39-8.gif) |
Carbamic acid, N-[(1S,2S,4S)-2-hydroxy-4-[[(2-methylpropoxy)carbonyl]amino]-5-phenyl-1-(phenylmethyl)pentyl]-, 5-thiazolylmethyl ester |
1010809-39-8 |
C28H35N3O5S |
![Piperazine, 1,4-bis[2-[(2,4-dimethylphenyl)thio]phenyl]-](/CAS/20200515/GIF/2243045-82-9.gif) |
Piperazine, 1,4-bis[2-[(2,4-dimethylphenyl)thio]phenyl]- |
2243045-82-9 |
C32H34N2S2 |
![2-amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)benzoic acid](/CAS/20210111/GIF/1640351-46-7.gif) |
2-amino-4-methoxy-5-(3-morpholin-4-ylpropoxy)benzoic acid |
1640351-46-7 |
C15H22N2O5 |
![3-Desoxyvitamin D3](/CAS/20200611/GIF/69662-75-5.gif) |
3-Desoxyvitamin D3 |
69662-75-5 |
C27H44 |
![cis-Vitamin K2](/CAS/20210111/GIF/65061-19-0.gif) |
cis-Vitamin K2 |
65061-19-0 |
C31H40O2 |
![N,N'-((5-methylisoxazole-3,4-diyl)bis(3,1-phenylenesulfonyl))dipropionamide disodium salt](/) |
N,N'-((5-methylisoxazole-3,4-diyl)bis(3,1-phenylenesulfonyl))dipropionamide disodium salt |
|
|
![Zanubrutinib Impurity](/) |
Zanubrutinib Impurity |
|
|
![(O-Isobutyryl (R)-Fesoterodine](/CAS/20210111/GIF/1795786-25-2.gif) |
(O-Isobutyryl (R)-Fesoterodine |
1795786-25-2 |
C30H43NO4 |
![Cefdinir Degradation Impurity 1](/) |
Cefdinir Degradation Impurity 1 |
|
|
![Cephalexin Impurity C2](/) |
Cephalexin Impurity C2 |
|
|
![Cefalexin Ethyl Homolog 2 Impurity](/) |
Cefalexin Ethyl Homolog 2 Impurity |
|
|
![Piperacillin Impurity P](/) |
Piperacillin Impurity P |
|
|
![1,1'-(((2R,2'R,4R,4'R)-4,4'-(oxybis(methylene))bis(2-(2,4-difluoro phenyl)tetrahydrofuran-4,2-diyl))bis(methylene))bis(1H-1,2,4-triazole)](/) |
1,1'-(((2R,2'R,4R,4'R)-4,4'-(oxybis(methylene))bis(2-(2,4-difluoro phenyl)tetrahydrofuran-4,2-diyl))bis(methylene))bis(1H-1,2,4-triazole) |
2256739-22-5 |
C28H28F4N6O3 |
![8-((R)-1-acryloylpiperidin-3-yl)-10-(4-phenoxyphenyl)-1,10b-dihydropyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one](/) |
8-((R)-1-acryloylpiperidin-3-yl)-10-(4-phenoxyphenyl)-1,10b-dihydropyrazolo[4,3-e]pyrimido[1,2-c]pyrimidin-2(8H)-one |
|
|
![Levosimendan Impurity 16](/CAS/20210111/GIF/2290570-69-1.gif) |
Levosimendan Impurity 16 |
2290570-69-1 |
C11H12N2O |
![Tolvaptan Impurity 11](/CAS/20210111/GIF/331947-69-4.gif) |
Tolvaptan Impurity 11 |
331947-69-4 |
C16H14ClNO2 |
![(S)-2-((R)-2,5-dioxo-3-propylpyrrolidin-1-yl)butanamide](/CAS/20211123/GIF/2432911-31-2.gif) |
(S)-2-((R)-2,5-dioxo-3-propylpyrrolidin-1-yl)butanamide |
2432911-31-2 |
C11H18N2O3 |
![(S)-N-((S)-1-amino-1-oxobutan-2-yl)-3-(bromomethyl)hexanamide](/) |
(S)-N-((S)-1-amino-1-oxobutan-2-yl)-3-(bromomethyl)hexanamide |
|
|
![Peramivir Impurity 17](/) |
Peramivir Impurity 17 |
|
|
![Peramivir Impurity 23](/) |
Peramivir Impurity 23 |
|
|
![Silodosin Carboxylic Acid Impurity](/CAS/20210111/GIF/1431373-77-1.gif) |
Silodosin Carboxylic Acid Impurity |
1431373-77-1 |
C25H31F3N2O5 |
![Pramipexole Impurity M](/) |
Pramipexole Impurity M |
|
|
![Premastast Impurity 2](/) |
Premastast Impurity 2 |
|
|
![Peramivir Impurity 26](/) |
Peramivir Impurity 26 |
|
|
![Peramivir Impurity 34](/) |
Peramivir Impurity 34 |
|
|
![(S)-2-(1-azabicyclo[2.2.2]oct-3-yl)-2,4,5,6-tetrahydro-1H-benz[de]isoquinolin-1-one hydrochloride](/) |
(S)-2-(1-azabicyclo[2.2.2]oct-3-yl)-2,4,5,6-tetrahydro-1H-benz[de]isoquinolin-1-one hydrochloride |
|
|
![Imatinib impurity BY](/) |
Imatinib impurity BY |
|
|
![6β-Methylprednisolone](/CAS/20180808/GIF/18462-27-6.gif) |
6β-Methylprednisolone |
18462-27-6 |
C22H30O5 |
![DEXTROMETHORPHAN N-OXIDE](/CAS/GIF/1177494-18-6.gif) |
DEXTROMETHORPHAN N-OXIDE |
1177494-18-6 |
C18H25NO2 |
![1-[(2-CHLOROPHENYL)DIPHENYLMETHYL]-1H-PYRAZOLE](/StructureFile/ChemBookStructure20/GIF/CB5646412.gif) |
1-[(2-CHLOROPHENYL)DIPHENYLMETHYL]-1H-PYRAZOLE |
|
C22H17ClN2 |
![Celecoxib Impurity 2](/StructureFile/ChemBookStructure22/GIF/CB5647277.gif) |
Celecoxib Impurity 2 |
948293-46-7 |
C11H9F3N2 |
![1-METHYL-4-PHENYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-AMINE](/CAS/GIF/63156-74-1.gif) |
1-METHYL-4-PHENYL-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-5-AMINE |
63156-74-1 |
C11H10F3N3 |
![AURORA KA-7735](/CAS/GIF/6487-86-1.gif) |
AURORA KA-7735 |
6487-86-1 |
C9H13NO2 |
![Sugammadex sodium Impurity 45](/) |
Sugammadex sodium Impurity 45 |
|
|
![Carboprost Trometamol 1](/) |
Carboprost Trometamol 1 |
|
|
![Tenofovir Impurity 113](/CAS/20210111/GIF/1335287-28-9.gif) |
Tenofovir Impurity 113 |
1335287-28-9 |
C11H13IN4O |
![Cefazolin USP Impurity L-δ3](/) |
Cefazolin USP Impurity L-δ3 |
|
|
![Cabozantinib impurity 38](/) |
Cabozantinib impurity 38 |
|
|
![2-epi-(-)-EMtricitabine](/CAS/GIF/145416-34-8.gif) |
2-epi-(-)-EMtricitabine |
145416-34-8 |
C8H10FN3O3S |
![Parent nucleus of cefotiaM hydrochloride](/CAS/20180808/GIF/372092-19-8.gif) |
Parent nucleus of cefotiaM hydrochloride |
372092-19-8 |
C13H21N7O3S2 |
![Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate)](/CAS/20150408/GIF/111664-35-8.gif) |
Bisacodyl Related Compound E (20 mg) (2-[(4-Acetoxyphenyl)(pyridin-2-yl)methyl]phenyl acetate) |
111664-35-8 |
C22H19NO4 |
![6-(2,5-dichlorophenyl)-1,3,5-Triazine-2,4(1H,3H)-dione](/CAS/GIF/30222-00-5.gif) |
6-(2,5-dichlorophenyl)-1,3,5-Triazine-2,4(1H,3H)-dione |
30222-00-5 |
C9H5Cl2N3O2 |
![(2'R)-2'-Deoxy-2'-fluoro-2'-Methyl-uridine 3',5'-dibenzoate](/CAS/GIF/863329-65-1.gif) |
(2'R)-2'-Deoxy-2'-fluoro-2'-Methyl-uridine 3',5'-dibenzoate |
863329-65-1 |
C24H21FN2O7 |
![Celecoxib iMpurity-A](/) |
Celecoxib iMpurity-A |
|
|
![EMtricitabine iMpurity A](/) |
EMtricitabine iMpurity A |
|
|
![RocuroniuMbroMide iMpurity D](/) |
RocuroniuMbroMide iMpurity D |
|
|
![(3S,4R)-4-(4-Fluorophenyl)piperidine-3-Methanol Hydrochloride](/CAS/GIF/220548-73-2.gif) |
(3S,4R)-4-(4-Fluorophenyl)piperidine-3-Methanol Hydrochloride |
220548-73-2 |
C12H17ClFNO |
![Cabozantinib impurity 57](/) |
Cabozantinib impurity 57 |
|
|
![(2R,3S)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol hydrochloride](/) |
(2R,3S)-3-(6-(1-(6-chloro-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidin-4-yl)-2-(2,4-difluorophenyl)-1-(1H-1,2,4-triazol-1-yl)butan-2-ol hydrochloride |
|
|
![(R)-2-((2R,5R)-3,6-dioxo-5-phenylpiperazin-2-yl)-5-methyl-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid](/CAS/20210111/GIF/860011-30-9.gif) |
(R)-2-((2R,5R)-3,6-dioxo-5-phenylpiperazin-2-yl)-5-methyl-3,6-dihydro-2H-1,3-thiazine-4-carboxylic acid |
860011-30-9 |
C16H17N3O4S |
![Dapoxetine impurity 54](/) |
Dapoxetine impurity 54 |
|
|
![Doxofylline Impurity 21](/) |
Doxofylline Impurity 21 |
|
|
![Dapoxetine impurity 60](/) |
Dapoxetine impurity 60 |
|
|
![Bosutinib Impurity 37](/CAS/20210305/GIF/2095306-27-5.gif) |
Bosutinib Impurity 37 |
2095306-27-5 |
C39H30Cl4N6O6 |
![3-Hydroxy-1-methylindolin-5,6-dion](/CAS/GIF/54-06-8.gif) |
3-Hydroxy-1-methylindolin-5,6-dion |
54-06-8 |
C9H9NO3 |
![TELMISARTAN-D3](/StructureFile/ChemBookStructure9/GIF/CB5730269.gif) |
TELMISARTAN-D3 |
1189889-44-8 |
C33H27D3N4O2 |
![4-(4-Chlor-1,2,5-thiadiazol-3-yl)morpholin](/CAS/GIF/30165-96-9.gif) |
4-(4-Chlor-1,2,5-thiadiazol-3-yl)morpholin |
30165-96-9 |
C6H8ClN3OS |
![Atomoxetine impurity D CRS](/CAS/20210111/GIF/873310-29-3.gif) |
Atomoxetine impurity D CRS |
873310-29-3 |
C17H21NO |
![Beraprost Impurity 2](/) |
Beraprost Impurity 2 |
|
|
![Brivudine Impurity 2](/) |
Brivudine Impurity 2 |
|
|
![3-METHOXYCARBONYLAMINO-4-METHYLPYRIDINE](/CAS/GIF/694495-63-1.gif) |
3-METHOXYCARBONYLAMINO-4-METHYLPYRIDINE |
694495-63-1 |
C8H10N2O2 |
![4-chloro-6-(1-(6-ethyl-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidine](/) |
4-chloro-6-(1-(6-ethyl-5-fluoropyrimidin-4-yl)ethyl)-5-fluoropyrimidine |
|
|
![Empagliflozin Impurity 74](/) |
Empagliflozin Impurity 74 |
|
|
![Empagliflozin Impurity 78](/) |
Empagliflozin Impurity 78 |
|
|
![Empagliflozin Impurity 85](/) |
Empagliflozin Impurity 85 |
|
|
![Relugolix Impurity 11](/) |
Relugolix Impurity 11 |
|
|
![LaMotrigine IMpurity D](/CAS/GIF/661463-79-2.gif) |
LaMotrigine IMpurity D |
661463-79-2 |
C9H5Cl2N3O2 |
![DeMethylpiperazinyl Desethyl Sildenafil Sulfonyl Chloride](/CAS/GIF/139756-27-7.gif) |
DeMethylpiperazinyl Desethyl Sildenafil Sulfonyl Chloride |
139756-27-7 |
C15H15ClN4O4S |
![Rizatriptan IMpurity B](/CAS/GIF/1016900-28-9.gif) |
Rizatriptan IMpurity B |
1016900-28-9 |
C13H15ClN5 |
![rac Adrenaline IMpurity D](/CAS/GIF/1095714-91-2.gif) |
rac Adrenaline IMpurity D |
1095714-91-2 |
C16H19NO3 |
![2-(1-Methylethenyl)-6-(1-Methylethyl)phenol](/CAS/GIF/74926-89-9.gif) |
2-(1-Methylethenyl)-6-(1-Methylethyl)phenol |
74926-89-9 |
C12H16O |
![Irinotecan IMpurity G](/CAS/GIF/947687-02-7.gif) |
Irinotecan IMpurity G |
947687-02-7 |
C35H42N4O6 |
![5-[Bis(2-hydroxyethyl)aMino]-1-Methyl-1H-benziMidazole-2-butanoic Acid](/CAS/GIF/109882-30-6.gif) |
5-[Bis(2-hydroxyethyl)aMino]-1-Methyl-1H-benziMidazole-2-butanoic Acid |
109882-30-6 |
C16H23N3O4 |
![5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide](/CAS/GIF/325855-74-1.gif) |
5-Chloro-6'-Methyl-3-[4-(Methylsulfonyl)phenyl]-2,3'-bipyridine 1'-Oxide |
325855-74-1 |
C18H15ClN2O3S |
![Lafutidine IMpuritiy B](/CAS/20150408/GIF/174583-84-7.gif) |
Lafutidine IMpuritiy B |
174583-84-7 |
C22H29N3O5S |
![N-(Methylsulfonyl)-N-(2-phenoxyphenyl)MethanesulfonaMide](/CAS/GIF/905858-63-1.gif) |
N-(Methylsulfonyl)-N-(2-phenoxyphenyl)MethanesulfonaMide |
905858-63-1 |
C14H15NO5S2 |
![4,5-Dihydro-α,3-diMethyl-5-oxo-1-phenyl-α-sulfo-1H-pyrazole-4-acetic Acid](/CAS/GIF/1357477-99-6.gif) |
4,5-Dihydro-α,3-diMethyl-5-oxo-1-phenyl-α-sulfo-1H-pyrazole-4-acetic Acid |
1357477-99-6 |
C13H14N2O6S |
![tert-butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoyl)piperazine-1-carboxylate](/CAS/GIF/763114-04-1.gif) |
tert-butyl 4-(2-fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)Methyl)benzoyl)piperazine-1-carboxylate |
763114-04-1 |
C25H27FN4O4 |
![1H-IMidazole, 4-Methyl-1-[3-nitro-5-(trifluoroMethyl)phenyl]-](/CAS/GIF/916975-92-3.gif) |
1H-IMidazole, 4-Methyl-1-[3-nitro-5-(trifluoroMethyl)phenyl]- |
916975-92-3 |
C11H8F3N3O2 |
![Edaravone iMpurity P3](/CAS/20150408/GIF/1323485-71-7.gif) |
Edaravone iMpurity P3 |
1323485-71-7 |
C13H16N2O4S |
![Ondansetron Impurity B](/) |
Ondansetron Impurity B |
|
|
![LeflunoMide EP IMpurity F](/CAS/20210111/GIF/1403564-06-6.gif) |
LeflunoMide EP IMpurity F |
1403564-06-6 |
C12H9F3N2O2 |
![4'-((1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl)biphenyl-2-carboxylic acid](/) |
4'-((1,7'-dimethyl-2'-propyl-1H,1'H-2,5'-bibenzo[d]imidazol-1'-yl)methyl)biphenyl-2-carboxylic acid |
|
|
![Itraconazole iMpurity D](/) |
Itraconazole iMpurity D |
|
|
![3-amino-2-chloroacrolein](/CAS/GIF/221615-73-2.gif) |
3-amino-2-chloroacrolein |
221615-73-2 |
C3H4ClNO |
![3-Amino-4-pyrazolecarbonitrile](/CAS/GIF/16617-46-2.gif) |
3-Amino-4-pyrazolecarbonitrile |
16617-46-2 |
C4H4N4 |
![BenzaMide, 3,4-bis(cyclopropylMethoxy)-N-(3,5-dichloro-4-pyridinyl)-](/CAS/GIF/1391052-24-6.gif) |
BenzaMide, 3,4-bis(cyclopropylMethoxy)-N-(3,5-dichloro-4-pyridinyl)- |
1391052-24-6 |
C20H20Cl2N2O3 |
![4-ISOBUTYRYLACETOPHENONE](/CAS/GIF/103931-20-0.gif) |
4-ISOBUTYRYLACETOPHENONE |
103931-20-0 |
C12H14O2 |
![ButanaMide, 4-hydroxy-N-(1-Methylethyl)-](/CAS/GIF/42042-66-0.gif) |
ButanaMide, 4-hydroxy-N-(1-Methylethyl)- |
42042-66-0 |
C7H15NO2 |
![5H-chroMeno[2,3-b]pyridin-7-ylacetic acid](/CAS/GIF/52549-07-2.gif) |
5H-chroMeno[2,3-b]pyridin-7-ylacetic acid |
52549-07-2 |
C14H11NO3 |
![IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin)](/) |
IMp. B (EP): (2RS,4S)-2-[[[[3-(2-Chloro-6-fluorophenyl)-5-Methylisoxazol-4-yl]carbonyl]aMino]Methyl]-5,5-diMethyl- thiazolidine-4-carboxylic Acid (Penilloic Acids of Flucloxacillin) |
|
|
![IMp. C (EP): (4-(DiphenylMethyl)-1,1-bis[(E)-3-phenylprop-2-enyl]piperaziniuM Chloride](/CAS/20211123/GIF/95062-18-3.gif) |
IMp. C (EP): (4-(DiphenylMethyl)-1,1-bis[(E)-3-phenylprop-2-enyl]piperaziniuM Chloride |
95062-18-3 |
C35H35ClF2N2 |
![IMp. E (EP): 4-AMino-5-(ethylsulphonyl)-2-Methoxybenzoic Acid](/) |
IMp. E (EP): 4-AMino-5-(ethylsulphonyl)-2-Methoxybenzoic Acid |
|
|